SCHEMBL28057775

SCHEMBL28057775

O=S(=O)(c1ccc(F)cc1)C1CCC(O)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 8/20 0.46
HTR2C P28335 7/20 0.46
KCNH2 Q12809 7/20 0.46
DRD2 P14416 4/20 0.42
MMP13 P45452 2/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
MMP1 P03956 1/20 0.41
MMP2 P08253 1/20 0.41
MMP9 P14780 1/20 0.41
MMP8 P22894 1/20 0.41
EPHX2 P34913 1/20 0.41
PSEN1 P49768 1/20 0.40
PSEN2 P49810 1/20 0.40
APH1B Q8WW43 1/20 0.40
NCSTN Q92542 1/20 0.40
APH1A Q96BI3 1/20 0.40
PSENEN Q9NZ42 1/20 0.40
PTGS2 P35354 1/20 0.38
F2 P00734 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL644453 0.90 HTR2A (0.51) HTR2AHTR2CKCNH2DRD2MMP13
SCHEMBL643581 0.82 HTR2A (0.49) HTR2AHTR2CKCNH2DRD2MMP13
SCHEMBL3240288 0.82 HTR2A (0.49) HTR2AHTR2CKCNH2DRD2MMP13
SCHEMBL31435684 0.81 GAA (0.43) MMP13CA1CA2MMP1MMP2
SCHEMBL11120903 0.81 HTR2A (0.51) HTR2AHTR2CKCNH2DRD2ALDH1A1
Formic Acid SCHEMBL28110710 0.79 HTR2A (0.44) HTR2AHTR2CKCNH2DRD2MMP13
SCHEMBL5212828 0.78 CYP11B1 (0.49) HTR2AHTR2CKCNH2DRD2EPHX2
SCHEMBL28343860 0.78 HTR2A (0.46) HTR2AHTR2CKCNH2DRD2MMP13
SCHEMBL13043174 0.77 MMP13 (0.63) MMP13CA1CA2MMP1MMP2
Hydrochloric Acid SCHEMBL4095644 0.76 CYP11B1 (0.48) HTR2AHTR2CKCNH2DRD2EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105531268-B Noval chemical compound and its pharmaceutical composition for treating cystic fibrosis 加拉佩格斯股份有限公司 2017-09-12 CN disclosed
CN-105531268-A Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis GALAPAGOS NV 2016-04-27 CN disclosed